Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of October 2019
Date Filed: October 30, 2019
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The document serves primarily as a cover sheet incorporating other information by reference.
Important Facts for Investors to Verify
- The filing incorporates by reference Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417); investors should review these documents for detailed financials.
- The registrant files annual reports under Form 20-F.
- The report was signed by Geoffrey Kempler, Executive Chairman.
- Specific financial metrics for the period are absent from this text and must be sourced from the referenced appendices or other filings.